Accès ouvert
2026
article
OpenAlex
Leonie Hoermann, Fatma Burcu Şeker, Emanuel Joseph, Sabrina V. Kirchleitner et autres
Abstract Background Translocator protein (TSPO)-PET imaging facilitates monitoring of glioblastoma in preclinical models and patients. However, specificity of TSPO-PET signals remains to be investigated. In this study, we aimed to decipher exact contributions of cellular and extracellular compartments including the impact of …
Accès ouvert
2026
article
OpenAlex
Gloria Mueller, Artem Zatcepin, Laura M. Bartos, Leonie Hoermann et autres
Abstract Purpose Strong expression of the 18 kDa translocator protein (TSPO) is observed in glioma and tumor-associated myeloid cells within the tumor microenvironment. However, TSPO expression also extends beyond the tumor and may reflect systemic immune regulation. We therefore assessed inter-organ associations …
de, us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
M. Brendel, Laura M. Bartos, Ruoqing Feng, K Mueller et autres
de, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
M. Haertel, Rebecca Schaefer, Lea H. Kunze, Ha Eun Park et autres
de, us
(code pays fourni par la source)
2024
article
OpenAlex
Lina Dinkel, Selina Hummel, Valerio Zenatti, Mariagiovanna Malara et autres
Niemann-Pick type C (NPC) disease is an inherited lysosomal storage disorder mainly driven by mutations in the NPC1 gene, causing lipid accumulation within late endosomes/lysosomes and resulting in progressive neurodegeneration. Although microglial activation precedes neuronal loss, it remains elusive whether loss of …
de, us, se, ch
(code pays fourni par la source)
Accès ouvert
2024
other
OpenAlex
Laura M. Bartos, Stefanie Quach, Valerio Zenatti, Sabrina V. Kirchleitner et autres
Contralateral hemispheres of SB28 glioblastoma mice indicate signatures of disease-associated myeloid cells and immunosuppression. A, Volcano plot highlights genes with significant upregulation and downregulation in the contralateral hemisphere of SB28 glioblastoma mice (red and blue, respectively) compared to sham. B, qPCR reveals …
Accès ouvert
2024
other
OpenAlex
Laura M. Bartos, Stefanie Quach, Valerio Zenatti, Sabrina V. Kirchleitner et autres
Characteristics of the cohort.
Accès ouvert
2024
other
OpenAlex
Laura M. Bartos, Stefanie Quach, Valerio Zenatti, Sabrina V. Kirchleitner et autres
Elevated TSPO-PET signals in the non-lesional hemisphere of patients with glioblastoma. A, Patient selection process. Patients receiving TSPO-PET imaging at initial diagnosis of glioma were allocated. Patients with unilateral manifestation of glioblastoma (WHO IV; n = 41) or isocitrate dehydrogenase mutant astrocytoma …
Accès ouvert
2024
other
OpenAlex
Laura M. Bartos, Stefanie Quach, Valerio Zenatti, Sabrina V. Kirchleitner et autres
Contralateral TSPO-PET signal elevation is associated with persisting epileptic seizures and worse overall survival. A, Contralateral TSPO-PET shows no quantitative difference between patients presenting with (n = 20) and without (n = 20) epileptic seizures at inital diagnosis (top). Significant increase of …
Accès ouvert
2024
other
OpenAlex
Laura M. Bartos, Stefanie Quach, Valerio Zenatti, Sabrina V. Kirchleitner et autres
Contralateral TSPO-PET signal elevation is associated with tumor phenotype and localization. A and B, Correlation of contralateral TSPO-PET signals in patients with glioblastoma (n = 38) with the TSPO-PET signal of the tumor (A) and the tumor volume in TSPO-PET, FET-PET (B, …
Accès ouvert
2024
other
OpenAlex
Laura M. Bartos, Stefanie Quach, Valerio Zenatti, Sabrina V. Kirchleitner et autres
AbstractPurpose: Current therapy strategies still provide only limited success in the treatment of glioblastoma, the most frequent primary brain tumor in adults. In addition to the characterization of the tumor microenvironment, global changes in the brain of patients with glioblastoma have been …
Accès ouvert
2024
supplementary-materials
OpenAlex
Laura M. Bartos, Stefanie Quach, Valerio Zenatti, Sabrina V. Kirchleitner et autres
Supplementary Figures 1, 2 Supplementary Tables 1 - 3 inlucing Representativeness of Study Participants" supplementary table (Supplementary Table 1)